Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-517
Closed -$220K 230
2025
Q4
$220K Sell
517
-152
-23% -$65.1K 0.03% 217
2025
Q3
$318K Buy
669
+16
+2% +$7.58K 0.05% 165
2025
Q2
$306K Buy
653
+2
+0.3% +$913 0.05% 168
2025
Q1
$303K Buy
651
+90
+16% +$40.5K 0.05% 157
2024
Q4
$235K Buy
561
+43
+8% +$19.6K 0.04% 183
2024
Q3
$247K Buy
518
+15
+3% +$6.84K 0.04% 177
2024
Q2
$221K Buy
+503
New +$221K 0.04% 181
2023
Q4
Sell
-1,145
Closed -$426K 192
2023
Q3
$426K Sell
1,145
-24
-2% -$9.13K 0.1% 106
2023
Q2
$445K Buy
+1,169
New +$427K 0.1% 108

Other funds holding LIN

CFO4Life Group's LIN Position: Q1 2026 in Review

CFO4Life Group sold out of Linde (LIN) in Q1 2026, closing a stake of 517 shares — an estimated $220K sold.

CFO4Life Group first reported a position in LIN in Q2 2023 and held it in 9 quarters. The position peaked at $445K in Q2 2023. 2,267 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • CFO4Life Group reported no remaining Linde position as of Q1 2026 after selling out during the quarter.
  • CFO4Life Group sold 517 Linde shares in Q1 2026, an estimated $220K.
  • CFO4Life Group first reported a position in Linde in Q2 2023 and held it in 9 quarters.
  • CFO4Life Group's Linde position peaked at $445K in Q2 2023.
  • 2,267 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.